258 related articles for article (PubMed ID: 2501837)
1. Bactericidal and bacteriolytic action of peptide antibiotic AS-48 against gram-positive and gram-negative bacteria and other organisms.
Gálvez A; Maqueda M; Martínez-Bueno M; Valdivia E
Res Microbiol; 1989 Jan; 140(1):57-68. PubMed ID: 2501837
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal Activity and Mechanism of Photoirradiated Polyphenols against Gram-Positive and -Negative Bacteria.
Nakamura K; Ishiyama K; Sheng H; Ikai H; Kanno T; Niwano Y
J Agric Food Chem; 2015 Sep; 63(35):7707-13. PubMed ID: 25660393
[TBL] [Abstract][Full Text] [Related]
4. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
Farrell DJ; Robbins M; Rhys-Williams W; Love WG
Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Multidrug-Resistant Gram-Positive and Gram-Negative Bacteria by a Photoactivated Porphyrin.
Bondi M; Mazzini A; de Niederhäusern S; Iseppi R; Messi P
Pol J Microbiol; 2017 Dec; 66(4):533-536. PubMed ID: 29319507
[TBL] [Abstract][Full Text] [Related]
7. In-vitro selection of bacteria resistant to the 4-quinolone agents.
Limb DI; Dabbs DJ; Spencer RC
J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
[TBL] [Abstract][Full Text] [Related]
8. Characterization and partial purification of a broad spectrum antibiotic AS-48 produced by Streptococcus faecalis.
Gálvez A; Maqueda M; Valdivia E; Quesada A; Montoya E
Can J Microbiol; 1986 Oct; 32(10):765-71. PubMed ID: 3098396
[TBL] [Abstract][Full Text] [Related]
9. Gepotidacin (GSK2140944)
Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of cefpirome (HR810) against antibiotic-resistant gram-positive and gram-negative bacteria including organisms with inducible resistance.
Murray PR; Niles AC
Diagn Microbiol Infect Dis; 1986 Jan; 4(1):53-63. PubMed ID: 3632921
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of cecropins.
Moore AJ; Beazley WD; Bibby MC; Devine DA
J Antimicrob Chemother; 1996 Jun; 37(6):1077-89. PubMed ID: 8836811
[TBL] [Abstract][Full Text] [Related]
12. Unravelling the mechanism of action of "de novo" designed peptide P1 with model membranes and gram-positive and gram-negative bacteria.
Espeche JC; Martínez M; Maturana P; Cutró A; Semorile L; Maffia PC; Hollmann A
Arch Biochem Biophys; 2020 Oct; 693():108549. PubMed ID: 32828795
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
Biedenbach DJ; Beach ML; Jones RN
Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
[TBL] [Abstract][Full Text] [Related]
14. A class IIa peptide from Enterococcus mundtii inhibits bacteria associated with otitis media.
Knoetze H; Todorov SD; Dicks LM
Int J Antimicrob Agents; 2008 Mar; 31(3):228-34. PubMed ID: 18155886
[TBL] [Abstract][Full Text] [Related]
15. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
Cole EC; Addison RM; Rubino JR; Leese KE; Dulaney PD; Newell MS; Wilkins J; Gaber DJ; Wineinger T; Criger DA
J Appl Microbiol; 2003; 95(4):664-76. PubMed ID: 12969278
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
Morfin-Otero R; Noriega ER; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in rizgary hospital - Erbil.
Al-Naqshbandi AA; Chawsheen MA; Abdulqader HH
J Infect Public Health; 2019; 12(3):330-336. PubMed ID: 30522892
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin.
Bouanchaud DH
J Antimicrob Chemother; 1997 May; 39 Suppl A():15-21. PubMed ID: 9511057
[TBL] [Abstract][Full Text] [Related]
19. Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies.
Dhanda G; Sarkar P; Samaddar S; Haldar J
J Med Chem; 2019 Apr; 62(7):3184-3205. PubMed ID: 30404451
[TBL] [Abstract][Full Text] [Related]
20. Protamine-like proteins have bactericidal activity. The first evidence in Mytilus galloprovincialis.
Notariale R; Basile A; Montana E; Romano NC; Cacciapuoti MG; Aliberti F; Gesuele R; De Ruberto F; Sorbo S; Tenore GC; Guida M; Good KV; Ausió J; Piscopo M
Acta Biochim Pol; 2018 Nov; 65(4):585-594. PubMed ID: 30447153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
